Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis

被引:13
作者
Chen, Yunxin [1 ]
Tan, Soo-Yong [2 ]
Petersson, Bengt Fredrik [3 ]
Khor, Yiu Ming [4 ]
Gopalakrishnan, Sathish Kumar [5 ]
Tan, Daryl [6 ]
机构
[1] Singapore Gen Hosp, Dept Haematol, Acad Level 3,Outram Rd, Singapore 169608, Singapore
[2] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore
[3] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore
[4] Singapore Gen Hosp, Dept Nucl Med & PET, Singapore, Singapore
[5] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[6] Raffles Hosp, Singapore Gen Hosp, Dept Haematol, Raffles Canc Ctr, Singapore, Singapore
关键词
MEITL; MATK; CLINICAL-FEATURES; PET;
D O I
10.1002/hon.2288
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Monomorphic epitheliotropic intestinal T-cell lymphomas (MEITL), formerly Type II enteropathy-associated T-cell lymphomas (EATL), are rare peripheral T-cell lymphomas. They are associated with poor survival outcomes, in part because of their late diagnosis. Although MEITLs may be reliably diagnosed based on histological and immunophenotypic findings, overlaps with other NWT and T-cell lymphomas may confound the diagnosis. The distinctive high-level nuclear staining of the novel marker Megakaryocyte-associated tyrosine kinase (MATK) in MEITLs is an invaluable tool in distinguishing ME.ITI, from classical EATI, and other NWT or T-cell lymphomas. 18-Fluorine-2-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) has been shown to be a useful tool in the staging and follow-up of aggressive lymphomas. Herein, we describe an unusual case of occult hepatic recurrence of MEITL that was non-avid on F-18-FUG PET, in which diagnosis was confirmed based on the expression of MATK in tumour cells. Copyright (C) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:852 / 855
页数:4
相关论文
共 12 条
[1]   Classic Versus Type II Enteropathy-Associated T-Cell Lymphoma Diagnostic Considerations [J].
Arps, David P. ;
Smith, Lauren B. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (09) :1227-1231
[2]   Type II Enteropathy-Associated T-Cell Lymphoma: A Distinct Aggressive Lymphoma With Frequent γδ T-cell Receptor Expression [J].
Chan, John K. C. ;
Chan, Alexander C. L. ;
Cheuk, Wah ;
Wan, Suk-King ;
Lee, Wai-Ki ;
Lui, Yun-Hoi ;
Chan, Wai-Kong .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (10) :1557-1569
[3]   Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project [J].
Delabie, Jan ;
Holte, Harald ;
Vose, Julie M. ;
Ullrich, Fred ;
Jaffe, Elaine S. ;
Savage, Kerry J. ;
Connors, Joseph M. ;
Rimsza, Lisa ;
Harris, Nancy L. ;
Mueller-Hermelink, Konrad ;
Ruediger, Thomas ;
Coiffier, Bertrand ;
Gascoyne, Randy D. ;
Berger, Francoise ;
Tobinai, Kensei ;
Au, Wing Y. ;
Liang, Raymond ;
Montserrat, Emili ;
Hochberg, Ephraim P. ;
Pileri, Stefano ;
Federico, Massimo ;
Nathwani, Bharat ;
Armitage, James O. ;
Weisenburger, Dennis D. .
BLOOD, 2011, 118 (01) :148-155
[4]   Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center [J].
Gale, J ;
Simmonds, PD ;
Mead, GM ;
Sweetenham, JW ;
Wright, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :795-803
[5]  
Hadithi M, 2006, J NUCL MED, V47, P1622
[6]   FDG-PET in T-cell and NK-cell neoplasms [J].
Kako, S. ;
Izutsu, K. ;
Ota, Y. ;
Minatani, Y. ;
Sugaya, M. ;
Momose, T. ;
Ohtomo, K. ;
Kanda, Y. ;
Chiba, S. ;
Motokura, T. ;
Kurokawa, M. .
ANNALS OF ONCOLOGY, 2007, 18 (10) :1685-1690
[7]  
Karanam PK, 2015, BR J HAEMATOL
[8]   Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies [J].
Sieniawski, Michal K. ;
Lennard, Anne L. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (04) :231-240
[9]   Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype [J].
Tan, S-Y ;
Chuang, S-S ;
Tang, T. ;
Tan, L. ;
Ko, Y-H ;
Chuah, K-L ;
Ng, S-B ;
Chng, W-J ;
Gatter, K. ;
Loong, F. ;
Liu, Y-H ;
Hosking, P. ;
Cheah, P-L ;
Teh, B-T ;
Tay, K. ;
Koh, M. ;
Lim, S-T .
LEUKEMIA, 2013, 27 (08) :1688-1696
[10]   Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma [J].
Tan, S-Y ;
Ooi, A-S ;
Ang, M-K ;
Koh, M. ;
Wong, J-C ;
Dykema, K. ;
Ngeow, J. ;
Loong, S. ;
Gatter, K. ;
Tan, L. ;
Lim, L-C ;
Furge, K. ;
Tao, M. ;
Lim, S-T ;
Loong, F. ;
Cheah, P. L. ;
Teh, B-T .
LEUKEMIA, 2011, 25 (03) :555-557